FindTrial
Sign In

Clinical characteristics of pathologically confirmed pulmonary cryptococcosis in patients with non-acquired immunodeficiency syndrome and the value of cryptococcus latex agglutination test for diagnosis and efficacy evaluation

Clinical characteristics of pathologically confirmed pulmonary cryptococcosis in patients with non-acquired immunodeficiency syndrome and the value of cryptococcus latex agglutination test for diagnosis and efficacy evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035805
Enrollment
Unknown
Registered
2020-08-17
Start date
2020-08-15
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary cryptococcosis

Interventions

case series:non-intervention

Sponsors

Institute of Antibiotics, Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In-patients in Huashan Hospital from Jan.1,1999 to Dec.31,2019, with pathologically confirmed pulmonary cryptococcosis and blood HIV(-).

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
cryptococcus latex agglutination test;—

Countries

China

Contacts

Public ContactWang Minggui

Huashan Hospital, Fudan University

mgwang@fudan.edu.cn+86 13916230765

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026